R&D | April 15, 2026
Regeneron and Telix strike major radiopharma pact in push into next-gen cancer therapies
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
The study’s multi-technology design is intended to improve reproducibility, strengthen regulatory-grade evidence generation
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
MoU aims to strengthen academia-industry collaboration in healthcare research and innovation
These surgeries involve no bone cuts, minimal surgical trauma, smaller incisions and significantly reduced blood loss
The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
Experts also underscored the growing role of technologies such as tele-neurorehabilitation, robotics, and AI-driven therapies in improving recovery outcomes
The approval clears the way for a US study at leading clinical centers to evaluate the safety and effectiveness of VDYNE’s system in patients
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
